If the video player gets updated in this script to where the video will play in the post, not in a popup iframe. The video posts should also have a view counter to indicate how many times it's been watched. I like how effort is being put in here to show a more accurate timestamp with status and such, I think a view counter on videos would help too.

Also, I'd give the audio feature an upgrade as well with a newer look as a post type. Maybe like a SoundCloud wave look to it or something.

Again, no rush to fix bugs or add in suggested features. Keep up the good work.

#colibrism #suggestions

Google ads/other ad code only shows up for the first 15 status updates or threads. After that they don't load in between posts, only the sidebar ad will show. After the 15 posts, it will only show site ads that users bought from you.

In the next update if possible can you make it where the timeline updates to load more posts to also keep showing the google ads alongside site ads.
#colibrism #ads #feature #pleaseandthanks

Ration Card Status UP : राशन कार्ड स्टेटस 2021-2022 ऑनलाइन ...
https://rationcardslist.in › ration-card-...
· Translate this page
इसके बाद आप जिस जिले (District) से हो आपको उस जिले का नाम सेलेक्ट करना है और उस पर क्लिक करना ...

UP Ration Card NFSA : राशन कार्ड नई लिस्ट | fcs.up.gov.in 2022
https://rationcardslist.in
· Translate this page

UP Ration Card 2022 : fcs.up.gov.in 2022 - NFSA UP Ration Card New Update - योगी सरकार का बड़ा ऐलान - अप्रैल से जून 2022 तक ...

At-home blood collection and micro sampling devices market is projected to grow at a CAGR of 10.7 %.
Roots Analysis has done a detailed study on At-Home Blood Collection and Micro Sampling Devices market, 2021-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 190 page report, which features 95+ figures and 110+ tables, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Key Market Insights
 The ongoing COVID-19 pandemic has accelerated the pace at which the healthcare sector is evolving, thereby, spurring innovations that allow patients to collect blood samples at-home as well as monitor their health remotely
 Presently, close to 50 at-home blood collection and micro sampling devices are available / being developed; majority of the firms engaged in this domain are start ups or small companies located in the US
 Most of the at-home devices intended for collection of whole capillary blood are presently marketed; DBS technology, used for preparation of dried blood spot cards, has emerged as the most popular platform
 In pursuit of gaining a competitive edge, stakeholders are actively expanding their product portfolios and upgrading their devices, via incorporation of advanced features
 Over the years, the intellectual property related to blood collection devices has grown at a commendable pace, with majority of the patents being filed by industry players
 The growing interest of the stakeholders is also reflected from the recent rise in partnership activity; a significant proportion of the deals inked till date were focused on market expansion
 To support the ongoing innovation in this domain, private and public investors have made substantial capital investments, worth ~USD 650 million, in initiatives of various industry stakeholders
 Given the favourable increase in adoption of at-home blood collection and micro sampling devices during the COVID-19 pandemic, the market is anticipated to witness significant growth in the foreseen future

For more information, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling

3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes

3.8. Future Perspectives

4. MARKET OVERVIEW
4. Market Overview
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area

4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Num

Top Selling Biologics Market, 2021-2030

To order this 320+ page report, please visit this link

Key Inclusions
 A detailed assessment of the current market landscape of top selling biologics, along with information on developers (such as year of establishment, company size, location of headquarters and current portfolio of top selling biologics), type of biologic, route of administration, target gene / antigen, type of packaging format, disease indication and target therapeutic area.

 It also provides an in-depth analysis of key therapeutic areas, such as oncological disorders, metabolic disorders, autoimmune disorders, gastrointestinal disorders, ophthalmic disorders, CNS/ Neurological disorders, cardiovascular disorders, blood disorders, respiratory disorders, bone disorders and others, in companies that are engaged in the development of top selling biologics.

 A detailed analysis of revenues generated by top selling biologics (60+) between 2016 and 2020. It includes information on reasons for significant increase / decrease in their sales in the given time span. It also includes the analysis of revenues generated by top selling biologics in 2020, based on several relevant parameters, such as type of biologic and developer.
 An analysis of the completed, ongoing, and planned clinical studies for top selling biologics. The trials considered in the analysis were analyzed based on several relevant parameters, such as trial registration year, trial recruitment status, enrolled patient population, study design, target therapeutic area, geographical location of trials and leading organizations. It is worth highlighting that these studies were registered to evaluate the already approved top selling biologics for potential combinations, device evaluations and comparisons.
 A detailed analysis on the key promotional strategies that are being / have been adopted by developers of top selling biologics. It further includes a detailed Harvey ball analysis highlighting the extent of promotional content on product websites of all biologics (60+) that fall into this criterion. Additionally, it features detailed profiles, presenting promotional strategies implemented for top 7 blockbuster biologics (in terms of revenues), along with information on their promotional content on product websites (covering key messages for patients and healthcare professionals), details of patient support programs and a brief section on DTC advertisements.
 A brief analysis of the product lifecycle management strategies, such as geographical expansion, approval for additional disease indications, reformulations, combination therapies, exploiting alternate routes of administration reimbursement programs and pricing strategies, that have been adopted by stakeholders engaged in the development of top selling biologics, during the period 2016-2020. The information in detail has been provided for top 10 biologics (in terms of revenues).
 An elaborate analysis representing annual treatment cost of top selling biologics. It includes grid representations, providing information on 60+ top selling biologics, based on type of biologic.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Biologic
 Monoclonal Antibodies
 Hormones
 Fusion Proteins
 Enzymes
 Interferons
 Antibody Fragments
 Gene Therapies
 Vaccines

 Key Developers
 Genentech / Roche
 AbbVie
 Janssen Biotech / Johnson & Johnson
 Amgen
 Eli Lilly
 Bristol Myers Squibb
 Sanofi
 Novo Nordisk
 Regeneron

To request sample pages, please visit this link

Key Questions Answered
 Which biologics are likely to attain the blockbuster status in the foreseen future?
 Who are the leading players engaged in the development of top selling biologics?
 Which key clinical conditions are presently targeted by top selling biologics?
 What are the historical global sales of top selling biologics?
 Which are the most commonly adopted product life cycle management strategies by players for their top selling products?
 What is the current annual treatment cost associated with top selling biologics?
 Which regions have emerged as the key hubs for conducting clinical studies focused on top selling biologics?
 How has the biosimilars landscape in this market evolved over the past few years?
 Which factors are likely to influence the evolution of this market?
 How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:
1. Novel T-Cell Immunotherapies Market, 2021-2030
2. TIL-based Therapies Market, 2021-2030
3. Non-Hormonal Therapies Market, 2021-2030
4. Gene Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030
5. Global T-Cell Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com

Biologics market is projected to be worth USD 156 billion by 2030.
Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant market share over the past couple of decades

Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings.

Over the years, around 200 biologics have been approved for the treatment of various disease indications in the US and Europe. In 2020, 18 new biologics received approval by the USFDA. Despite their complex and cost intensive manufacturing protocols, biopharmaceuticals (once approved) are considered to be highly profitable assets. In the recent past, many biological interventions have achieved blockbuster status (in some cases, registering revenues worth over USD 4 billion a year); prominent examples include (arranged in decreasing order of 2020 revenues) Humira®, Keytruda®, Stelara®, Opdivo®, Avastin®, Trulicity®, Enbrel®, Ocrevus™ and Rituxan®.

To order this 320+ page report, which features 190+ figures and 195+ tables, please visit this https://www.rootsanalysis.com/reports/top-selling-biologics-market.html
Key Market Insights
More than 65 top selling biologics (revenues equal to or above USD 500 million in 2020) are currently available in the market
Majority (54%) of the aforementioned candidates are monoclonal antibodies, followed by hormones (19%) and enzymes (9%). Further, subcutaneous route (50%) emerged as the most preferred route of administration for such therapies, followed by the intravenous route (40%).

More than 50% the developers of top selling biologics are based in North America
The top selling biologics market is currently dominated by the presence of large companies (82%). Additionally, majority of such players were established before the year 2000.

Over 2,450 clinical trials registered for the evaluation of top selling biologics, till Q3 2020
Of the total, 1,892 trials were registered for the evaluation of products targeting oncological disorders, followed by those investigating biologics intended for the treatment of metabolic disorders (122) and autoimmune disorders (98).

Around 250 biosimilars of top selling biologics are currently approved / under development
Close to 30% of the aforementioned candidates have already been approved. It is worth mentioning that over 100 biosimilars have received approval in Asia Pacific. Within this region, India and South Korea emerged as key hubs, having granted maximum approvals for biosimilars of top selling biologics (in terms of 2020 revenues).

Monoclonal antibodies are anticipated to capture over 75% of the market share by 2030
Over 40% of the market share is anticipated to be capture by Genentech / Roche and Merck by 2030. It is worth mentioning that as the patents of the currently marketed products have already / are expected to expire towards the end of the forecast period, the market is likely to reach maturity.

To request a sample copy / brochure of this report, please visit this
https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html
Key Questions Answered
 Which biologics are likely to attain the blockbuster status in the foreseen future?
 Who are the leading players engaged in the development of top selling biologics?
 Which key clinical conditions are presently targeted by top selling biologics?
 What are the historical global sales of top selling biologics?
 Which are the most commonly adopted product life cycle management strategies by players for their top selling products?
 What is the current annual treatment cost associated with top selling biologics?
 Which regions have emerged as the key hubs for conducting clinical studies focused on top selling biologics?
 How has the biosimilars landscape in this market evolved over the past few years?
 Which factors are likely to influence the evolution of this market?
 How is the current and future market opportunity likely to be distributed across key market segments?

The USD 156 billion (by 2030) financial opportunity associated with the top selling biologics market has been analyzed across the following segments:
Type of Biologic
 Monoclonal Antibodies
 Hormones
 Fusion Proteins
 Enzymes
 Interferons
 Antibody Fragments
 Gene Therapies
 Vaccines

Key Developers
 Genentech / Roche
 AbbVie
 Janssen Biotech / Johnson & Johnson
 Amgen
 Eli Lilly
 Bristol Myers Squibb
 Sanofi
 Novo Nordisk
 Regeneron

For additional details, please visit
https://www.rootsanalysis.com/reports/top-selling-biologics-market.html or email salesrootsanalysis.com

You may also be interested in the following titles:
1. Novel T-Cell Immunotherapies Market, 2021-2030
2. TIL-based Therapies Market, 2021-2030
3. Non-Hormonal Therapies Market, 2021-2030
4. Gene Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030
5. Global T-Cell Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com

*STATUSHUB* - இந்த ஆப்-ல ஜாயின் பண்ணா ₹10 ஜாயினிங் போனஸ் தராங்க! மேலும் நீங்கள் சேர்த்து விடும் ஒவ்வொரு நபருக்கும் ₹10 போனஸ் கிடைக்கும். மொத்தமாக ₹100 வந்ததும் பணத்தை பேடிஎம்,அல்லது யுபிஐ வழியாக எடுத்துக் கொள்ளலாம்.

இந்த ஆப்-இல் நீங்கள் பார்க்கும் இமேஜ் / வீடியோ-விற்கும் பாயிண்ட்ஸ் கிடைக்கும். நீங்கள் அப்லோட் செய்யும் ஒவ்வொரு இமேஜ் / வீடியோ-விற்கும் உங்களுக்கு பாயிண்ட்ஸ் கிடைக்கும். இந்த பாயிண்ட்ஸை நீங்கள் பணமாக மாற்றிக் கொள்ளலாம்.

வாருங்கள் ஜாலியாக பணம் வெல்ல!
டவுண்லோட் லிங்க்: https://play.google.com/store/apps/details?id=com.halite.statushub

***நீங்கள் இந்த ஆப்-இல் ஜாயின் செய்யும் பொழுது ₹10 போனஸ் கிடைக்க இந்த ரெஃபரென்ஸ் கோட்-ஐ "c45c523c" (without quote) பயன்படுத்தவும். நீங்கள் சேர்க்கும் நபருக்கு உங்கள் ரெஃபரென்ஸ் கோட்-ஐ ஷேர் செய்யவும்*

Hi mert_ks

Add Relevant people ( right sidebar )
And
Add "Reply, Like, and Repost"

in next update Teskale please 🙏 thank you

Exemple here :
https://twitter.com/NetflixFilm/status/1484437416513454080

#ideas #twitter #Teskale

What about a point system where users earn points for posting a status, and you can use those points to unlock the verified badge, or to help promote posts, maybe even to cash-out points. Or use them for achievements by becoming a stand-out creator on the platform? #ideas

Thank you for your kind response The script is missing a lot and it brought you all the things we need and want you to add in the next update
[Added] Banned Usernames
[Added] Banned Email Providers
[Added] Custom Ban Message
[Added] Hide Banned Users from Search Results
[Added] Hide Banned Users from Friends, Followings & Followers List
[Added] Hide Banned User’s Posts
[Added] Crop/Edit Profile Photo for Users
[Added] Adjust Profile Cover Position for Users
[Added] Phone Code in Signup Form
[Added] New SMS BulkSMS provider
[Added] New SMS Infobip provider
[Added] New Storage Digitalocean
[Added] New Storage FTP
[Added] New Payemnts CoinPayments
[Added] New Payemnts 2Checkout
[Added] Chat Typing Status
[Added] Chat Seen Status
[Added] Two-Factor Authentication via Email & Phone
[Added] Two-Factor Authentication via Google Authenticator App
[Added] Security Check (Password Required) to change Email or Username
[Added] Security Check (Password Required) to delete account

@mansur_TL TheBlackLoki
#ColibriBugs #oioo #أويوو #أويو #colibrism #moapprequest #moappbugs

Thank you for your kind response The script is missing a lot and it brought you all the things we need and want you to add in the next update
[Added] Banned Usernames
[Added] Banned Email Providers
[Added] Custom Ban Message
[Added] Hide Banned Users from Search Results
[Added] Hide Banned Users from Friends, Followings & Followers List
[Added] Hide Banned User’s Posts
[Added] Crop/Edit Profile Photo for Users
[Added] Adjust Profile Cover Position for Users
[Added] Phone Code in Signup Form
[Added] New SMS BulkSMS provider
[Added] New SMS Infobip provider
[Added] New Storage Digitalocean
[Added] New Storage FTP
[Added] New Payemnts CoinPayments
[Added] New Payemnts 2Checkout
[Added] Chat Typing Status
[Added] Chat Seen Status
[Added] Two-Factor Authentication via Email & Phone
[Added] Two-Factor Authentication via Google Authenticator App
[Added] Security Check (Password Required) to change Email or Username
[Added] Security Check (Password Required) to delete account

@mansur_TL
#ColibriBugs #oioo #أويوو #أويو